SU11248 (Sunitinib) does inhibit tumor growth and angiogenesis in an ovarian cancer murine xenograft model

被引：0
|
作者：
Bauerschlag, D. O.
Schem, C.
Tiwari, S.
Meinhold-Heerlein, I.
Mundhenke, C.
Weigel, M.
Egberts, J. H.
Kalthoff, H.
Jonat, W.
Maass, N.
机构：
[1] Univ Hosp Kiel Germany, Kiel, Germany
[2] Univ Hosp, Kiel, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.16557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16557
引用
收藏
页数：1
相关论文
共 50 条
  • [21] SU11248 and STI-571, small molecule inhibitors of Kit and PDGFR inhibit growth of SCLC preclinical models
    Abrams, TJ
    Lee, LB
    Murray, LJ
    Pryer, NK
    Cherrington, JM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S80 - S80
  • [22] Assessment of tumor perfusion by (oxygen-15)-water PET imaging during treatment with sunitinib malate (SU11248) in patients with advanced malignancies
    Mitchell, P
    Scott, AM
    O'Keefe, G
    Saunder, T
    Hicks, RJ
    Poon, A
    Baum, C
    Brega, N
    McCarthy, T
    Toner, G
    ANNALS OF ONCOLOGY, 2006, 17 : 32 - 33
  • [23] The multitargeted kinase inhibitor sunitinib malate (SU11248): soluble protein biomarkers of pharmacodynamic activity in patients with metastatic renal cell cancer
    DePrimo, S.
    Bello, C.
    Smeraglia, J.
    Shalinsky, D.
    Freddo, J.
    Baum, C.
    Rini, R.
    Michaelson, M.
    Motzer, R.
    Spinella, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 420 - 420
  • [24] Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer
    Jardim-Perassi, Bruna Victorasso
    Arbab, Ali S.
    Ferreira, Livia Carvalho
    Borin, Thaiz Ferraz
    Varma, Nadimpalli R. S.
    Iskander, A. S. M.
    Shankar, Adarsh
    Ali, Meser M.
    Pires de Campos Zuccari, Debora Aparecida
    PLOS ONE, 2014, 9 (01):
  • [25] Food does not effect the pharmacolkinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor, in healthy subjects.
    Bello, C
    Laurie, S
    Zhou, JH
    Verkh, L
    Smeraglia, J
    Mount, J
    Klamerus, K
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9076S - 9076S
  • [26] SU11248 (sunitinib malate) therapy in patients with refractory metastatic breast cancer: preliminary safety and efficacy results from a phase II study
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 172 - 172
  • [27] Tumor perfusion as assessed by (oxygen-15)-water PET imaging during treatment with sunitinib malate (SU11248) in patients with advanced malignancies.
    Scott, AM
    Mitchell, P
    O'Keefe, G
    Saunder, T
    Hicks, RJ
    Poon, A
    Baum, C
    Brega, N
    McCarthy, T
    Toner, G
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9129S - 9129S
  • [28] Sunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model
    Kumar, Ram Mohan Ram
    Arlt, Matthias J. E.
    Kuzmanov, Aleksandar
    Born, Walter
    Fuchs, Bruno
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (07): : 2156 - +
  • [29] Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model
    Moon, Young Jin
    Shin, Beom Soo
    An, Guohua
    Morris, Marilyn E.
    PHARMACEUTICAL RESEARCH, 2008, 25 (09) : 2158 - 2163
  • [30] Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model
    Young Jin Moon
    Beom Soo Shin
    Guohua An
    Marilyn E. Morris
    Pharmaceutical Research, 2008, 25
12345